HealthQuad Invests in LifeSigns to Scale AI-Led Patient Monitoring
The fresh funds will support global expansion, technology upgrades, product integrations, and scaling AI-driven patient monitoring across healthcare systems.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
HealthQuad, the growth venture arm of Quadria Group, has announced an investment in Chennai-based health-tech company LifeSigns.
The partnership is aimed at advancing AI-led predictive patient monitoring and supporting the company’s global expansion plans.
Founded in 2019 by Hari Subramaniam, Shouri Akkineni, and Dr Girish Chandra, LifeSigns provides continuous patient monitoring solutions using wireless biosensors and AI-driven analytics. Its platform enables real-time tracking of vital signs across hospitals, ambulances, and home care settings, helping clinicians make timely decisions.
HealthQuad said the collaboration will focus on expanding LifeSigns’ presence in Southeast Asia and the Gulf Cooperation Council (GCC) region, while also strengthening its technology stack through targeted integrations. Backed by Quadria Group’s global healthcare network, the investment is expected to provide both capital and strategic support.
Rahul Agarwal, Partner at HealthQuad, said, “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale.”
LifeSigns has developed a US-FDA approved platform that combines wearable medical devices, a cloud-based dashboard, and an AI engine. The system monitors key vitals such as ECG, heart rate, respiration, temperature, blood pressure, and oxygen levels. According to the company, its AI models can identify early signs of patient deterioration up to 26 hours in advance.
Since its inception, LifeSigns claims to have monitored more than 325,000 patients and generated over 87,000 critical alerts across more than 50 hospitals in India. The platform has also been associated with a reduction in emergency incidents and ICU readmissions.
Hari Subramaniam, Founder and CEO of LifeSigns, said, “No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India.”
He added, “With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard.”
Founded in 2016, HealthQuad manages over USD 350 million, backing scalable healthcare solutions globally.
HealthQuad, the growth venture arm of Quadria Group, has announced an investment in Chennai-based health-tech company LifeSigns.
The partnership is aimed at advancing AI-led predictive patient monitoring and supporting the company’s global expansion plans.
Founded in 2019 by Hari Subramaniam, Shouri Akkineni, and Dr Girish Chandra, LifeSigns provides continuous patient monitoring solutions using wireless biosensors and AI-driven analytics. Its platform enables real-time tracking of vital signs across hospitals, ambulances, and home care settings, helping clinicians make timely decisions.